the benefits of glp-1 drugs beyond obesity Can one drug do it

Ask About Payment Plans Some pharmacies or doctors might let us pay in bits instead of all at once

For patients using insulin or sulfonylureas, reducing their doses by 25% when starting GLP-1 therapy can help avoid hypoglycemia

Exenatide prolonged the gastric half-emptying time in all diabetic patients without gastroparesis ( n = 20) and worsened the gastric emptying in two of ten diabetics with pre-existing mild gastroparesis [56]

Debose-Boyd RA, Ye J

doi: 10.1016/S0140-6736(15)00803-X 36 BendottiGMontefuscoLLunatiMEUsuelliVPastoreILazzaroniEet al

GIP medications, while promising, require more research to fully understand their efficacy in diverse groups